• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:赵方允.基于二次审方软件对静脉用药滴速与浓度药学干预的模式实践[J].中国现代应用药学,2026,43(2):129-136.
zhaofangyun.The mode practice of pharmaceutical intervention on drip rate and concentration of intravenous drugs based on secondary prescription software[J].Chin J Mod Appl Pharm(中国现代应用药学),2026,43(2):129-136.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 8次   下载 0 本文二维码信息
码上扫一扫!
基于二次审方软件对静脉用药滴速与浓度药学干预的模式实践
赵方允
昆明市延安医院
摘要:
目的 鉴于医院药学实践中在医嘱审核方面存在无法有效审核静脉用药的情况,通过设计开发二次审方软件,开展对静脉用药滴速与浓度进行药学干预的模式实践,深入探究二次审方软件在合理用药方面所发挥的作用与成效。方法 PIVAS 审方药师依据药品说明书、指南等相关信息,并依托 PIVAS 系统的基础信息,同时结合当前处方和医嘱审核中遭遇的问题,有针对性地进行二次审方软件的研发设计。针对静脉用药的浓度、滴速信息予以规范,确立审核规则,设计审方模块,对存在的不适宜用药类别实施有效审核。结果 开发的二次审方软件能够切实审查出静脉用药浓度和滴速的不合理现象,对存在不适宜用药的类别进行有效甄别,从而提升医嘱的合格率。结论 二次审方软件的运用,能够为临床给予及时、精确的用药警示,有效干预不合理的医嘱,填补现有审方软件的缺陷,提高审方工作的效率。为临床用药提供坚实有力的指导,增强药师的服务价值,保证临床用药的合理性。
关键词:  PIVAS,静脉用药,浓度,滴速,二次审方,药学实践
DOI:
分类号:
基金项目:云南省高层次卫生计生技术人才培养经费资助(H-2019026);云南省科技厅,云南省科技厅科技计划项目基础研究专项(202301AT070482);云南省科技厅,云南省科技厅-昆明医科大学应用基础研究联合专项资金面上项目(202301AT070001-178);云南省教育厅科学研究(2024J2078)
The mode practice of pharmaceutical intervention on drip rate and concentration of intravenous drugs based on secondary prescription software
zhaofangyun
Yan’an Hospital Affiliated to Kunming Medical University
Abstract:
Objective To explore the role and effectiveness of the secondary prescription review software in rational drug use through the design and development of the secondary prescription review software to carry out the mode practice of pharmaceutical intervention on the drip rate and concentration of intravenous drugs. Methods PIVAS prescription-reviewing pharmacists developed and designed the secondary prescription-reviewing software according to the relevant information such as drug instructions and guidelines, the basic information of PIVAS system, and the problems encountered in the current prescription and medical order review. According to the concentration and drip rate information of intravenous drugs, the review rules were established, and the review module was designed to carry out effective review of the unsuitable drugs. Results The software developed for secondary prescription review could effectively examine the unreasonable phenomenon of intravenous drug concentration and drip rate, and effectively screen the category of inappropriate drugs, so as to improve the qualified rate of medical orders. Conclusion The application of secondary prescription review software can give timely and accurate drug warnings for clinical use, effectively intervene in unreasonable medical orders, fill the defects of existing prescription review software, and improve the efficiency of prescription review work. To provide solid and powerful guidance for clinical drug use, enhance the service value of pharmacists and ensure the rationality of clinical drug use.
Key words:  PIVAS, prescribing  pharmacist, concentration, drip  rate, secondary  prescribing software, inappropriate  medical prescription
扫一扫关注本刊微信